RSCM
Rock Springs Capital Management Portfolio holdings
AUM
$1.6B
1-Year Return
25.98%
This Quarter Return
+15.75%
1 Year Return
+25.98%
3 Year Return
+194.74%
5 Year Return
+336.76%
10 Year Return
+2,199.29%
AUM
$3.94B
AUM Growth
+$295M
(+8.1%)
Cap. Flow
+$40.9M
Cap. Flow
% of AUM
1.04%
Top 10 Holdings %
Top 10 Hldgs %
26.69%
Holding
163
New
20
Increased
50
Reduced
30
Closed
15
Top Buys
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$50.5M |
| 2 |
INZY
Inozyme Pharma
INZY
|
$23.1M |
| 3 |
Kymera Therapeutics
KYMR
|
$22.9M |
| 4 |
Acadia Pharmaceuticals
ACAD
|
$21.4M |
| 5 |
Humana
HUM
|
$21.3M |
Top Sells
| 1 |
PTLA
Portola Pharmaceuticals, Inc.
PTLA
|
$41.5M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
$31.6M |
| 3 |
Cigna
CI
|
$30.2M |
| 4 |
Amgen
AMGN
|
$29.7M |
| 5 |
Allogene Therapeutics
ALLO
|
$18.9M |
Sector Composition
| 1 | Healthcare | 90.05% |
| 2 | Consumer Staples | 1.43% |
| 3 | Consumer Discretionary | 0.93% |
| 4 | Industrials | 0.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Nkarta
NKTX
$149M
| $16.3M | 0.41% |
+540,873
| New | +$16.3M |
|
|
OSH
77
DELISTED
Oak Street Health, Inc.
OSH
| $16M | 0.41% |
+300,000
| New | +$16M |
|
|
ADAP
78
Adaptimmune Therapeutics
ADAP
$13.2M
| $15.9M | 0.4% |
1,986,910
| – | – |
|
79
uniQure
QURE
$932M
| $15.2M | 0.39% |
413,433
+6,300
| +2% | +$232K |
|
80
Amicus Therapeutics
FOLD
$2.46B
| $14.5M | 0.37% |
1,023,821
+7,000
| +0.7% | +$98.8K |
|
81
CONMED
CNMD
$1.68B
| $14.2M | 0.36% |
180,000
| – | – |
|
82
Spero Therapeutics
SPRO
$120M
| $13.8M | 0.35% |
1,236,256
+621,079
| +101% | +$6.93M |
|
83
Akero Therapeutics
AKRO
$3.48B
| $13M | 0.33% |
423,040
+180,055
| +74% | +$5.54M |
|
84
FibroGen
FGEN
$47M
| $12.7M | 0.32% |
12,371
-247
| -2% | -$254K |
|
|
ACCD
85
DELISTED
Accolade, Inc. Common Stock
ACCD
| $12.6M | 0.32% |
+325,000
| New | +$12.6M |
|
86
Aprea Therapeutics
APRE
$8.74M
| $12.5M | 0.32% |
25,915
| – | – |
|
87
Theravance Biopharma
TBPH
$699M
| $12.2M | 0.31% |
824,018
-4,200
| -0.5% | -$62.1K |
|
|
GWPH
88
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $11.6M | 0.29% |
119,188
-855
| -0.7% | -$83.2K |
|
|
FUSN
89
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
| $11.4M | 0.29% |
947,541
+10,500
| +1% | +$126K |
|
90
Rigel Pharmaceuticals
RIGL
$691M
| $11.4M | 0.29% |
474,289
-115,475
| -20% | -$2.77M |
|
91
Aurinia Pharmaceuticals
AUPH
$1.63B
| $11.4M | 0.29% |
+772,569
| New | +$11.4M |
|
92
Arvinas
ARVN
$557M
| $11.4M | 0.29% |
481,468
| – | – |
|
93
OneSpaWorld
OSW
$2.28B
| $11.3M | 0.29% |
1,740,000
| – | – |
|
94
Spyre Therapeutics
SYRE
$1.02B
| $11.3M | 0.29% |
63,621
| – | – |
|
|
TRIL
95
DELISTED
Trillium Therapeutics Inc.
TRIL
| $11M | 0.28% |
770,918
+8,300
| +1% | +$118K |
|
96
Prelude Therapeutics
PRLD
$65.7M
| $10.9M | 0.28% |
+360,263
| New | +$10.9M |
|
97
Protara Therapeutics
TARA
$123M
| $10.8M | 0.27% |
+643,622
| New | +$10.8M |
|
|
CNST
98
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
| $10.4M | 0.27% |
515,680
| – | – |
|
99
Prothena Corp
PRTA
$443M
| $10.2M | 0.26% |
1,025,207
+35,989
| +4% | +$360K |
|
100
Rhythm Pharmaceuticals
RYTM
$6.85B
| $10.1M | 0.26% |
464,086
-48,025
| -9% | -$1.04M |
|